United Services Automobile Association Takes Position in Encompass Health Corporation $EHC

Key Points

• United Services Automobile Association invested $666,000 in Encompass Health Corporation, acquiring a total of 6,606 shares.
• Several institutional investors have increased their stakes in Encompass Health, with Baird Financial boosting their stake by 1,147.0% during the fourth quarter.
• Encompass Health recently raised its quarterly dividend to $0.19 per share, marking an increase from the previous $0.17.

United Services Automobile Association bought a new position in Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 6,606 shares of the company's stock, valued at approximately $666,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. OneDigital Investment Advisors LLC bought a new position in Encompass Health in the first quarter worth approximately $263,000. GAMMA Investing LLC grew its position in shares of Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after buying an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC increased its stake in shares of Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after buying an additional 172 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Encompass Health by 30.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock valued at $972,000 after acquiring an additional 2,218 shares in the last quarter. Finally, Fifth Third Bancorp lifted its stake in Encompass Health by 88.7% in the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after acquiring an additional 2,017 shares during the period. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

Shares of NYSE EHC traded down $0.76 during mid-day trading on Friday, hitting $126.04. The stock had a trading volume of 551,583 shares, compared to its average volume of 633,963. The firm has a market cap of $12.69 billion, a PE ratio of 24.67, a PEG ratio of 2.22 and a beta of 0.92. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company has a 50 day moving average of $117.50 and a two-hundred day moving average of $112.76. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.15.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the business earned $1.11 EPS. The company's quarterly revenue was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's dividend payout ratio is 13.31%.

Insider Buying and Selling

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares of the company's stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Bank of America raised their target price on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Wednesday. UBS Group upped their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. KeyCorp boosted their price target on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research report on Thursday, June 5th. Finally, Truist Financial increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $137.71.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.